Tepezza Prescription Drug Lawsuit

Tepezza (Teprotumumab-trbw) is a Thyroid Eye Disease medication that has demonstrated an increased risk of hearing-related side effects including permanent hearing loss and tinnitus. Tinnitus is a condition in which the person suffering experiences a ringing or other noises in one or both ears. While “some” risk was disclosed by Horizon Pharmaceuticals when Tepezza was initially approved by the FDA, the risks are now known to be far greater.

In April of 2022, David Weibel of Illinois filed suit against Horizon, claiming that they failed to warn him or his doctors about the significant risks of hearing loss and tinnitus, which he further claims led directly to his permanent impairment. He took the drug from June 2021-September 2021, and began using it less than six months after it was approved by the FDA.

The lawsuit seeks punitive damages due to the claim in the complaint that Horizon allegedly “willfully, wantonly, and intentionally conspired, and acted in concert, to ignore relevant safety concerns and to deliberately not study the safety and efficacy of Tepezza” as required by law.

If you or a loved one received Tepezza infusions and later experienced hearing loss or tinnitus, you may be eligible to join the Tepezza Lawsuit.

If you do have a case, an attorney can:

• Verify your eligibility to take legal action during a free case evaluation
• Gather evidence like medical records and case details to build a strong case
• File your Tepezza lawsuit within relevant deadlines and statutes of limitations
• Negotiate potential settlement amounts
• Present your case, if necessary, to the trial court

To find out more about the Tepezza lawsuit and to see if you qualify to join, please contact a LifeWallet attorney who can further assist you. Please reach out as soon as possible, so that we can evaluate your case and ensure that the statute of limitations on related claims has not run.

If you have any questions and want to find out if you qualify, please contact LifeWallet at 305-614-2222.